4//SEC Filing
Pillar Invest Corp 4
Accession 0000899243-18-022726
CIK 0000861838other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:44 PM ET
Size
30.4 KB
Accession
0000899243-18-022726
Insider Transaction Report
Form 4
Pillar Pharmaceuticals I LP
Director10% Owner
Transactions
- Sale
Common Stock
2018-08-08$5.88/sh−50,000$294,190→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.29/sh−25,000$157,358→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.62/sh−75,000$421,717→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.97/sh−20,000$119,500→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.55/sh−91,893$510,098→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.89/sh−8,107$47,759→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.25/sh−15,000$93,762→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.35/sh−15,000$95,324→ 0 total(indirect: See Footnote)
Pillar Pharmaceuticals II, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2018-08-09$6.29/sh−25,000$157,358→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.35/sh−15,000$95,324→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.62/sh−75,000$421,717→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.55/sh−91,893$510,098→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.97/sh−20,000$119,500→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.89/sh−8,107$47,759→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.88/sh−50,000$294,190→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.25/sh−15,000$93,762→ 0 total(indirect: See Footnote)
Pillar Pharmaceuticals III, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2018-08-09$6.29/sh−25,000$157,358→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.88/sh−50,000$294,190→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.97/sh−20,000$119,500→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.35/sh−15,000$95,324→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.89/sh−8,107$47,759→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.62/sh−75,000$421,717→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.25/sh−15,000$93,762→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.55/sh−91,893$510,098→ 0 total(indirect: See Footnote)
Pillar Invest Corp
Director10% Owner
Transactions
- Sale
Common Stock
2018-08-08$5.89/sh−8,107$47,759→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.55/sh−91,893$510,098→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.97/sh−20,000$119,500→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.25/sh−15,000$93,762→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.35/sh−15,000$95,324→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-07$5.62/sh−75,000$421,717→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-08$5.88/sh−50,000$294,190→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-08-09$6.29/sh−25,000$157,358→ 0 total(indirect: See Footnote)
Footnotes (16)
- [F1]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.4000-$5.7509. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F10]Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 241,266 shares of common stock of the Issuer.
- [F11]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $6.1600-$6.3200. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F12]Shares sold by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 673,985 shares of common stock of the Issuer.
- [F13]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $6.1600-$6.4300. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F14]Shares sold by Pillar I. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 216,266 shares of common stock of the Issuer.
- [F15]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $6.3000-$6.4000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F16]Shares sold by Pillar III. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following this transaction, Pillar III owns directly 293,980 shares of common stock of the Issuer.
- [F2]Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 697,092 shares of common stock of the Issuer.
- [F3]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.3800-$5.8000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]Shares sold by Participations Besancon. Participations Besancon is a fund advised by Pillar GP. Pillar GP disclaims Section 16 beneficial ownership of the Besancon Warrants and the common stock underlying such warrants and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, resulting from fees payable to Pillar GP in its capacity as investment advisor to Besancon. Following this transaction, Participations Besancon owns directly 1,061,212 shares of common stock of the Issuer.
- [F5]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.8300-$6.0000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F6]Shares sold by Pillar II. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 688,985 shares of common stock of the Issuer.
- [F7]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.6300-$6.1100. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F8]Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"). Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following this transaction, Pillar III owns directly 308,980 shares of common stock of the Issuer.
- [F9]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $5.9500-$6.0000. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001534428
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:44 PM ET
- Size
- 30.4 KB